Importation and QP Release

Importation Services

At IMP Clinical Supply Services, we specialize in the streamlined importation of investigational medicinal products, devices, and ancillaries. Conducting clinical trials in Israel often involves navigating the complexities of international borders, particularly when transporting critical drug supplies and medical devices. Our dedicated importation personnel possess the expertise to navigate this intricate landscape.

Our committed team excels in addressing the relevant authorities, ensuring that all necessary documentation is prepared and submitted for obtaining the required licenses or dismissals essential for the upcoming importation process. We understand the challenges inherent in importing drug products and medical devices, and our personnel are adept at eliminating setbacks in the importation and distribution of supplies to investigational sites for use in clinical trials in Israel.

IMP Clinical Supply Services offers comprehensive customs release services for all drug products and devices, including cytotoxic, cannabis, and controlled drug products. Our expertise in handling diverse product categories ensures a smooth and compliant transition through the intricate customs processes.

Choose IMP for a seamless importation and customs release process that prioritizes compliance, efficiency, and the uninterrupted flow of essential supplies for your clinical trials.

Our import services for clinical trials in Israel include importation of:
  • Investigational Medicinal Products (IMPs)
  • Comparator drugs
  • Add-on therapy drugs (e.g. rescue medications)
  • Cannabis
  • Unlicensed products
  • Controlled drugs
  • Equipment and medical devices
  • Ancillaries
IMP holds Manufacturer's/ Importer's Authorization from the Israeli MoH
QP Release
Expert Qualified Persons for Clinical Excellence
At IMP Clinical Supply Services, our commitment to excellence extends to our in-house certified Qualified Persons (QPs) who play a pivotal role in ensuring the quality and compliance of your Investigational Medicinal Products (IMPs). Our QPs bring a wealth of experience and expertise, performing clinical batch certification and re-certification in strict accordance with the Ministry of Health (MOH) requirements.

Our dedicated QPs understand the critical nature of your clinical study, and their commitment is unwavering, guaranteeing that your IMPs are released within the specified time constraints of your clinical trial. This seamless QP release process not only meets regulatory standards but also contributes to the overall success and efficiency of your clinical trial. Trust IMP for a reliable QP release service that prioritizes the integrity and quality of your Investigational Medicinal Products.
Our QP services include:
  • Batch release
  • Pass-through depot, for urgent shipment requests
  • Consulting services concerning regulatory requirements

Related Articles

Clinical trials in Israel during the Iron Swords War
Clinical trials in Israel during the Iron Swords War

Amid the current situation in Israel, IMP Services remains steadfast in our commitment to support and provide innovative solutions for your clinical trial logistics. Our goal is to ensure seamless operations for your trials, tailored to meet your unique needs. We’re pleased to share the recent update from the Israeli Ministry of Health. This letter […]

Read more
Healthcare Resilience & Clinical Trials in Israel
Healthcare Resilience & Clinical Trials in Israel

We would like to share with our clients and colleagues this important letter regarding the priority given to clinical trials in Israel by the MoH. We are always here to assist you in your clinical trial. Feel free to reach out!

Read more

Contact Us

    Back to top